Growth factors and the development of diabetic nephropathy

被引:38
作者
Gunter Wolf
机构
[1] University of Hamburg, Department of Medicine, Div. of Nephrol. Rheumatol./Osteol., Hamburg D-20246
关键词
Vascular Endothelial Growth Factor; Diabetic Nephropathy; Mesangial Cell; Connective Tissue Growth Factor; Proximal Tubular Cell;
D O I
10.1007/s11892-003-0012-2
中图分类号
学科分类号
摘要
Growth factors play an important role in the development of functional and structural changes associated with diabetic nephropathy. Although it has been known for years that these factors are important for early renal hypertrophy and subsequent development of glomerulosclerosis and tubulointerstitial fibrosis, the exact molecular mechanism of many of these factors has only recently been more elucidated. Furthermore, growth factors also link the metabolic theory of diabetic complications with renal hemodynamic changes in diabetic nephropathy because some growth factors could directly influence glomerular hemodynamics and tubular transport in diabetic nephropathy. The high glucose environment with stimulated cellular uptake of glucose and accelerated nonenzymatic reactions resulting in Amadori-modified proteins and the later-developing advanced glycation end products are the main stimulators for intrarenal induction of growth factors. Intracellular generation of reactive species is an important signal intermediate in these stimulated expressions of growth factors. Taking into consideration the pivotal role of growth factors in the development of diabetic nephropathy, a therapeutic strategy to antagonize growth factor effects appears to be straightforward. However, the pleiotropic function of many of these factors and their physiologic role in normal renal homeostasis may make this approach difficult. Copyright © 2003 by Current Science Inc.
引用
收藏
页码:485 / 490
页数:5
相关论文
共 50 条
[11]  
Landau D., Israel E., Rivkis I., Et al., The effect of growth hormone on the development of diabetic kidney disease in rats, Nephrol. Dial. Transplant., 18, pp. 694-702, (2003)
[12]  
Sugimoto H., Shikata K., Makino H., Et al., Increased gene expression of insulin-like growth factor-I receptor in experimental diabetic rat glomeruli, Nephron, 72, pp. 648-653, (1996)
[13]  
Doublier S., Seurin D., Fouqueray B., Et al., Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1, Kidney Int., 57, pp. 2299-2307, (2000)
[14]  
Bellush L.L., Doublier S., Holland A.N., Et al., Protection against diabetes-induced nephropathy in growth hormone receptor/ binding protein gene-disrupted mice, Endocrinology, 141, pp. 163-168, (2000)
[15]  
Flyvbjerg A., Bennett W.F., Rasch R., Et al., Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy and urinary albumin excretion in experimental diabetes in mice, Diabetes, 48, pp. 377-382, (1999)
[16]  
Bak M., Thomsen K., Flyvbjerg A., Effects of the somatostatin analogue octreotide on renal function in conscious diabetic rats, Nephrol. Dial. Transplant., 16, pp. 2002-2007, (2001)
[17]  
Raz I., Rubinger D., Popovtzer M., Et al., Octreotide prevents the early increase in renal insulin-like growth factor biding protein 1 in streptozotocin diabetic rats, Diabetes, 47, pp. 924-930, (1998)
[18]  
Doi T., Striker L.J., Gibson C.C., Et al., Glomerular lesions in mice transgenic for growth hormone and insulin-like growth factor-I, Am. J. Pathol., 137, pp. 541-552, (1990)
[19]  
Tsuchida K.I., Cronin B., Sharma K., Novel aspects of transforming growth factor-beta in diabetic kidney disease, Nephron, 92, pp. 7-21, (2002)
[20]  
Yamagishi S.I., Inagaki Y., Okamoto T., Et al., Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells, Kidney Int., 63, pp. 464-473, (2003)